For help on how to get the results you want, see our search tips.
69 results
Medicine
Periodic safety update report single assessments Remove Periodic safety update report single assessments filter
Orphan designations Remove Orphan designations filter
Orphan designation status
Expired Remove Expired filter
-
List item
Orphan designation: proteolytic enzymes enriched in bromelain for: Treatment of partial deep dermal and full-thickness burns
Date of designation: 30/07/2002, Expired, Last updated: 15/02/2023 -
List item
Orphan designation: velaglucerase alfa for: Treatment of Gaucher disease
Date of designation: 06/06/2010, Expired, Last updated: 09/09/2022 -
List item
Orphan designation: N-(2,4-di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide (ivacaftor) for: Treatment of cystic fibrosis
Date of designation: 08/07/2008, Expired, Last updated: 10/08/2022 -
List item
Orphan designation: pasireotide for: Treatment of Cushing's disease
Date of designation: 08/10/2009, Expired, Last updated: 14/06/2022 -
List item
Orphan designation: Mannitolum for: Treatment of cystic fibrosis
Date of designation: 07/11/2005, Expired, Last updated: 05/05/2022 -
List item
Orphan designation: Mercaptopurine for: Treatment of acute lymphoblastic leukaemia
Date of designation: 30/04/2009, Expired, Last updated: 05/05/2022 -
List item
Orphan designation: N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium; 2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylate (tafamidis) for: Treatment of familial amyloid polyneuropathy
Date of designation: 28/08/2006, Expired, Last updated: 25/11/2021 -
List item
Orphan designation: hydrocortisone for: Treatment of adrenal insufficiency
Date of designation: 22/05/2006, Expired, Last updated: 25/11/2021 -
List item
Orphan designation: 1, 1'-[1,4-Phenylenebis (methylene)]-bis-1,4,8,11-tetraazacyclotetradecane (plerixafor) for: Treatment to mobilize progenitor cells prior to stem cell transplantation
Date of designation: 20/10/2004, Expired, Last updated: 10/08/2021 -
List item
Orphan designation: carglumic acid for: Treatment of propionic acidaemia
Date of designation: 07/11/2008, Expired, Last updated: 09/06/2021 -
List item
Orphan designation: carglumic acid for: Treatment of isovaleric acidaemia
Date of designation: 07/11/2008, Expired, Last updated: 09/06/2021 -
List item
Orphan designation: carglumic acid for: Treatment of methylmalonic acidaemia
Date of designation: 07/11/2008, Expired, Last updated: 09/06/2021 -
List item
Orphan designation: Pirfenidone for: Treatment of idiopathic pulmonary fibrosis
Date of designation: 16/11/2004, Expired, Last updated: 22/03/2021 -
List item
Orphan designation: icatibant acetate for: Treatment of angioedema
Date of designation: 18/02/2003, Expired, Last updated: 12/08/2020 -
List item
Orphan designation: nilotinib for: Treatment of chronic myeloid leukaemia
Date of designation: 22/05/2006, Expired, Last updated: 20/01/2020 -
List item
Orphan designation: trabectedin for: Treatment of ovarian cancer
Date of designation: 17/10/2003, Expired, Last updated: 27/11/2019 -
List item
Orphan designation: Eculizumab for: Treatment of paroxysmal nocturnal haemoglobinuria
Date of designation: 17/10/2003, Expired, Last updated: 20/11/2019 -
List item
Orphan designation: Aztreonam lysinate for: Treatment of Gram-negative bacterial lung infection in cystic fibrosis
Date of designation: 21/06/2004, Expired, Last updated: 16/10/2019 -
List item
Orphan designation: Muramyl tripeptide phosphatidyl ethanolamine for: Treatment of osteosarcoma
Date of designation: 21/06/2004, Expired, Last updated: 11/07/2019 -
List item
Orphan designation: Caffeine citrate for: Treatment of primary apnoea of premature newborns
Date of designation: 18/02/2003, Expired, Last updated: 11/07/2019 -
List item
Orphan designation: Histamine dihydrochloride for: Treatment of acute myeloid leukaemia
Date of designation: 11/04/2005, Expired, Last updated: 20/02/2019 -
List item
Orphan designation: miglustat for: Treatment of Niemann-Pick's disease, type C
Date of designation: 16/02/2006, Expired, Last updated: 20/02/2019 -
List item
Orphan designation: azacitidine for: Treatment of myelodysplastic syndromes
Date of designation: 06/02/2002, Expired, Last updated: 20/02/2019 -
List item
Orphan designation: azacitidine for: Treatment of acute myeloid leukaemia
Date of designation: 29/11/2007, Expired, Last updated: 20/02/2019 -
List item
Orphan designation: Rufinamide for: Treatment of Lennox-Gastaut syndrome
Date of designation: 20/10/2004, Expired, Last updated: 20/02/2019